Key Details
Price
$21.98Annual ROE
-40.17%Beta
1.88Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 28, 2025Recent annual earnings:
Feb 28, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sep 8, 2023Analyst ratings
Recent major analysts updates
Dec 11, 24 Jones Trading
HoldNov 13, 24 Baird
OutperformOct 25, 24 Guggenheim
BuySep 4, 24 Wedbush
OutperformJul 16, 24 Evercore ISI Group
OutperformMay 13, 24 Wells Fargo
OverweightMay 10, 24 BTIG
BuyMay 2, 24 Baird
OutperformMar 26, 24 Stifel
BuyMar 1, 24 Wells Fargo
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Spyre Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Spyre Therapeutics?
- Does Spyre Therapeutics pay dividends?
- What sector is Spyre Therapeutics in?
- What industry is Spyre Therapeutics in?
- What country is Spyre Therapeutics based in?
- When did Spyre Therapeutics go public?
- Is Spyre Therapeutics in the S&P 500?
- Is Spyre Therapeutics in the NASDAQ 100?
- Is Spyre Therapeutics in the Dow Jones?
- When was Spyre Therapeutics's last earnings report?
- When does Spyre Therapeutics report earnings?
- Should I buy Spyre Therapeutics stock now?
What is the ticker symbol for Spyre Therapeutics?
The ticker symbol for Spyre Therapeutics is NASDAQ:SYRE
Does Spyre Therapeutics pay dividends?
No, Spyre Therapeutics does not pay dividends
What sector is Spyre Therapeutics in?
Spyre Therapeutics is in the Healthcare sector
What industry is Spyre Therapeutics in?
Spyre Therapeutics is in the Biotechnology industry
What country is Spyre Therapeutics based in?
Spyre Therapeutics is headquartered in United States
When did Spyre Therapeutics go public?
Spyre Therapeutics's initial public offering (IPO) was on April 7, 2016
Is Spyre Therapeutics in the S&P 500?
No, Spyre Therapeutics is not included in the S&P 500 index
Is Spyre Therapeutics in the NASDAQ 100?
No, Spyre Therapeutics is not included in the NASDAQ 100 index
Is Spyre Therapeutics in the Dow Jones?
No, Spyre Therapeutics is not included in the Dow Jones index
When was Spyre Therapeutics's last earnings report?
Spyre Therapeutics's most recent earnings report was on Feb 28, 2025
When does Spyre Therapeutics report earnings?
The date for Spyre Therapeutics's next earnings report has not been announced yet
Should I buy Spyre Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions